QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
Go back to QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System| Qiagen NV (NYSE: QGEN) | Delayed: 39.41 +0.47 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.94 | 52 Week High | $28.50 | |||
| Open | $38.69 | 52 Week Low | $19.94 | |||
| Day High | $39.44 | P/E | 135.90 | |||
| Day Low | $38.69 | EPS | $0.29 | |||
| Volume | 3,629,145 | |||||
| (NYSE: QIA) | Delayed: 0.00 -10.35 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 0 | |||||
